相关实验视频
Updated: Jan 11, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
超越免疫疗法思考:实施多模式护理计划,以促进第四阶段黑色素瘤延长存活时间
Aravind Sreeram1, Michael A Postow2,3, Andrea P Moy4
1Department of Surgery, Gastric and Mixed Tumor Service.
Melanoma research
|November 10, 2025
概括
结合全身治疗,局部干预和基因组分析的多式疗法可以显著延长晚期黑色素瘤患者的生存期. 这种方法,包括为进展性病变进行手术,为具有挑战性的病例提供了持久反应的希望.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 基因组学就是基因组学.
背景情况:
- 转移性黑色素瘤治疗由免疫检查点抑制剂 (ICI) 彻底改变.
- 显著的患者进展发生在12个月内,尽管强大的ICI组合.
- 需要定义多式疗法与晚期黑色素瘤的全身治疗并肩作用.
研究的目的:
- 为了描述BRAF突变黑色素瘤患者的9年多模式治疗之旅.
- 突出多学科护理和基因组分析对延长生存时间的影响.
- 为了证明手术切除在晚期黑色素瘤中病变进展的好处.
主要方法:
- 系统治疗:抗CTLA4,抗PD1,向疗法.
- 局部治疗:立体射线手术,多重转移切除术.
- 基因组分析揭示了获得的NRAS突变.
主要成果:
- 通过综合护理,延长的生存时间超过了传统估计.
- 获得的NRAS突变告知了量身定制的治疗调整.
- 没有反应的病变的手术切除有助于长期生存.
结论:
- 综合局部疗法和分子分析与全身疗法的多式疗法至关重要.
- 持续的临床和分子监测指导个性化治疗策略.
- 这种综合性方法为历史上预后不佳的患者提供了持久的生存.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

